OliX Pharmaceuticals secures KRW 110 billion investment from L’Oréal venture fund and Weis

June 4, 2026

OliX Pharmaceuticals has raised KRW110 billion from L’Oréal’s BOLD venture fund and Weiss Asset Management to advance RNAi-based beauty and wellness innovation.

Search

RECENT PRESS RELEASES

Meta’s Wang Says AI Agents Will Redefine How We Relate to Technology

SWI Editorial Staff2026-06-05T04:02:01-07:00June 5, 2026|

5 Interesting Startup Deals You May Have Missed: On-Demand Custom Manufacturing, Underwate

SWI Editorial Staff2026-06-05T04:00:37-07:00June 5, 2026|

Michigan Senate panel mulls financial ‘Catch-22’ for farms pledged federal clean energy funding

SWI Editorial Staff2026-06-05T04:00:23-07:00June 5, 2026|

How South Korea’s stock boom sparked a currency crisis

SWI Editorial Staff2026-06-05T04:00:08-07:00June 5, 2026|

3IF Ventures secures $12m first close for Africa-focused inclusive insurance fund

SWI Editorial Staff2026-06-05T04:00:04-07:00June 5, 2026|

Morning Call Sheet: SpaceX hype fuels AI optimism as markets broaden

SWI Editorial Staff2026-06-05T04:00:03-07:00June 5, 2026|